HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Variations in apolipoprotein D and sigma non-opioid intracellular receptor 1 genes with relation to risk, severity and outcome of ischemic stroke.

AbstractBACKGROUND:
In experimental studies, the apolipoprotein D (APOD) and the sigma receptor type 1 (SIGMAR1) have been related to processes of brain damage, repair and plasticity.
METHODS:
We examined blood samples from 3081 ischemic stroke (IS) patients and 1595 control subjects regarding 10 single nucleotide polymorphisms (SNPs) in the APOD (chromosomal location 3q29) and SIGMAR1 (chromosomal location 9p13) genes to find possible associations with IS risk, IS severity (NIHSS-score) and recovery after IS (modified Rankin Scale, mRS, at 90 days). Simple/multiple logistic regression and Spearman's rho were utilized for the analyses.
RESULTS:
Among the SNPs analyzed, rs7659 within the APOD gene showed a possible association with stroke risk (OR = 1.12; 95% CI: 1.01-1.25; P = 0.029) and stroke severity (NIHSS ≥ 16) (OR = 0.70; 95% CI: 0.54-0.92; P = 0.009) when controlling for age, sex and vascular risk factors for stroke. No SNP showed an association with stroke recovery (mRS).
CONCLUSIONS:
We conclude that the SNP rs7659 within the APOD gene might be related to risk and severity of ischemic stroke in patients.
AuthorsHåkan Lövkvist, Ann-Cathrin Jönsson, Holger Luthman, Katarina Jood, Christina Jern, Tadeusz Wieloch, Arne Lindgren
JournalBMC neurology (BMC Neurol) Vol. 14 Pg. 191 (Sep 28 2014) ISSN: 1471-2377 [Electronic] England
PMID25261976 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Apolipoproteins D
  • Receptors, sigma
  • sigma-1 receptor
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Apolipoproteins D (genetics)
  • Brain Ischemia (epidemiology, genetics)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide
  • Receptors, sigma (genetics)
  • Recovery of Function
  • Registries (statistics & numerical data)
  • Risk
  • Severity of Illness Index
  • Stroke (epidemiology, genetics)
  • Sweden (epidemiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: